Development of a Surveillance Definition for United States-Mexico Binational Cases of Tuberculosis

Overview

Journal Public Health Rep

Publisher Sage Publications

Specialty Public Health

Date 2018 Mar 24

PMID 29570435

Authors

Rachel S Yelk Woodruff

Mark C Miner

Roque Miramontes

Affiliations

Soon will be listed here.

Abstract

Objectives: Consistently collected binational surveillance data are important in advocating for resources to manage and treat binational cases of tuberculosis (TB). The objective of this study was to develop a surveillance definition for binational (United States-Mexico) cases of TB to assess the burden on US TB program resources.

Methods: We collaborated with state and local TB program staff members in the United States to identify characteristics associated with binational cases of TB. We collected data on all cases of TB from 9 pilot sites in 5 states (Arizona, California, Colorado, New Mexico, and Texas) during January 1-June 30, 2014, that had at least 1 binational characteristic (eg, "crossed border while on TB treatment" and "received treatment in another country, coordinated by an established, US-funded, binational TB program"). A workgroup of US state, local, and federal partners reviewed results and used them to develop a practical surveillance definition.

Results: The pilot sites reported 87 cases of TB with at least 1 binational characteristic during the project period. The workgroup drafted a proposed surveillance definition to include 2 binational characteristics: "crossed border while on TB treatment" (34 of 87 cases, 39%) and "received treatment in another country, coordinated by an established, US-funded, binational TB program" (26 of 87 cases, 30%). Applying the new proposed definition, 39 of 87 pilot cases of TB (45%) met the definition of binational.

Conclusion: Input from partners who were responsible for the care and treatment of patients who cross the United States-Mexico border was crucial in defining a binational case of TB.

References

. Preventing and controlling tuberculosis along the U.S.-Mexico border. MMWR Recomm Rep. 2001; 50(RR-1):1-27. View

Fitchett J, Vallecillo A, Espitia C . Tuberculosis transmission across the United States-Mexico border. Rev Panam Salud Publica. 2011; 29(1):57-60. DOI: 10.1590/s1020-49892011000100009. View

Yuen C, Kammerer J, Marks K, Navin T, France A . Recent Transmission of Tuberculosis - United States, 2011-2014. PLoS One. 2016; 11(4):e0153728. PMC: 4833321. DOI: 10.1371/journal.pone.0153728. View

Baker B, Jeffries C, Moonan P . Decline in tuberculosis among Mexico-born persons in the United States, 2000-2010. Ann Am Thorac Soc. 2014; 11(4):480-8. PMC: 4747416. DOI: 10.1513/AnnalsATS.201402-065OC. View

. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep. 2005; 54(RR-15):1-47. View

DeSisto C, Broussard K, Escobedo M, Borntrager D, Alvarado-Ramy F, Waterman S . Border Lookout: Enhancing Tuberculosis Control on the United States-Mexico Border. Am J Trop Med Hyg. 2015; 93(4):747-51. PMC: 4596593. DOI: 10.4269/ajtmh.15-0300. View

Schneider E, Laserson K, Wells C, Moore M . Tuberculosis along the United States-Mexico border, 1993-2001. Rev Panam Salud Publica. 2004; 16(1):23-34. DOI: 10.1590/s1020-49892004000700004. View

Baker B, Moonan P . Characterizing tuberculosis genotype clusters along the United States-Mexico border. Int J Tuberc Lung Dis. 2014; 18(3):289-91. PMC: 4718565. DOI: 10.5588/ijtld.13.0684. View

Schwartzman K, Oxlade O, Barr R, Grimard F, Acosta I, Baez J . Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med. 2005; 353(10):1008-20. DOI: 10.1056/NEJMsa043194. View

10.

Woodruff R, Winston C, Miramontes R . Predicting U.S. tuberculosis case counts through 2020. PLoS One. 2013; 8(6):e65276. PMC: 3681901. DOI: 10.1371/journal.pone.0065276. View

11.

Tschampl C, Garnick D, Zuroweste E, Razavi M, Shepard D . Use of Transnational Services to Prevent Treatment Interruption in Tuberculosis-Infected Persons Who Leave the United States. Emerg Infect Dis. 2016; 22(3):417-25. PMC: 4766910. DOI: 10.3201/eid2203.141971. View

12.

Schneider D, Lobato M . Tuberculosis control among people in U.S. Immigration and Customs Enforcement custody. Am J Prev Med. 2007; 33(1):9-14. DOI: 10.1016/j.amepre.2007.02.044. View